I posted this article late last year. Interesting that trials are investigating the targeting of antigens to dendritic cells in vivo. Now have another read of the penultimate paragraph on page one of today's announcement.
References:
https://www.targetedonc.com/conference/sitc-2017/manipulating-dendritic-cells-for-cancer-immunity
https://hotcopper.com.au/threads/mi...3882329/page-10?post_id=29332094#.W1rGmFAzbIU
https://hotcopper.com.au/documentembed?id=uOMxKKzFkiWRTLKhOROKAxjvTDYC6gy+zxCZsO56ke92GA==
Tony
Ann: Successful In-vivo Results Peptide Vaccine T-Cell Expansion, page-8
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.29 |
Change
0.045(3.63%) |
Mkt cap ! $749.4M | |||
| Open | High | Low | Value | Volume |
| $1.25 | $1.29 | $1.25 | $337.0K | 265.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $1.23 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.29 | 58344 | 1 |
View Market Depth
| Last trade - 16.10pm 25/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |